Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Clinical trial NCT06703346 · COMPLETED
Trial details
- NCT number
- NCT06703346
- Sponsor
- USWM CT, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-31
- Primary completion
- 2024-03-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.